Interstitial lung disease: genes and variants
Explore variant evidence for Interstitial lung disease across 7 analyzed proteins (SFTPC, TERT, FGFR1, FGFR4, PDGFRA and 2 more). Linked ClinVar records include 1 pathogenic or likely pathogenic variants, 23 variants of uncertain significance and 13 with conflicting classifications.
Coverage includes proteins already analyzed in CATVariant, not every gene involved in this condition. Database links are associations, not an assessment of clinical gene–disease validity. Computable evidence prioritizes variants for expert review and does not reclassify them. Source labels are pooled across this disease family.
Data updated 2026-11-04. Automated aggregation, not a clinical review date.
Download variant evidence (CSV)
Genes linked to Interstitial lung disease
SFTPC: Surfactant protein C
It contributes to pulmonary surfactant organization and is produced specifically by alveolar type II cells. Dominant pathogenic variants can cause interstitial lung disease across infancy and adulthood, often through protein misfolding and toxic cellular stress.
1 ClinVar pathogenic / likely pathogenic and 9 uncertain variants in SFTPC have source records linked to Interstitial lung disease. Association strength is not clinical gene validity.
TERT: Telomerase reverse transcriptase
It extends telomeric DNA using an internal RNA template and helps counter progressive chromosome-end shortening in stem and proliferative cells. Loss-of-function variants cause telomere-biology disorders, while promoter activation and increased activity support unlimited proliferation in many cancers.
0 ClinVar pathogenic / likely pathogenic and 12 uncertain variants in TERT have source records linked to Interstitial lung disease. Association strength is not clinical gene validity.
FGFR1: Fibroblast growth factor receptor 1
Its fibroblast-growth-factor signaling controls proliferation, differentiation, migration, and developmental patterning in many tissues. Germline pathogenic variants can cause hypogonadotropic hypogonadism or craniosynostosis syndromes, while fusions and other activating alterations drive selected cancers.
0 ClinVar pathogenic / likely pathogenic and 0 uncertain variants in FGFR1 have source records linked to Interstitial lung disease. Association strength is not clinical gene validity.
FGFR4: Fibroblast growth factor receptor 4
It transmits fibroblast-growth-factor signals involved in metabolism, tissue repair, development, and cell proliferation, with FGF19 as an important metabolic ligand. Aberrant signaling can support tumor growth, and activating alterations are therapeutic targets in selected cancers.
0 ClinVar pathogenic / likely pathogenic and 0 uncertain variants in FGFR4 have source records linked to Interstitial lung disease. Association strength is not clinical gene validity.
PDGFRA: Platelet-derived growth factor receptor alpha
PDGF signaling through this pathway promotes proliferation, survival, and migration of mesenchymal progenitors. Activating mutations or fusions drive gastrointestinal stromal tumors and selected hematologic and solid malignancies and can create kinase-inhibitor sensitivity.
0 ClinVar pathogenic / likely pathogenic and 0 uncertain variants in PDGFRA have source records linked to Interstitial lung disease. Association strength is not clinical gene validity.
PDGFRB: Platelet-derived growth factor receptor beta
Its signaling supports pericytes, vascular smooth-muscle cells, and other mesenchymal lineages during growth and tissue repair. Oncogenic fusions drive myeloid neoplasms, while germline activating or loss-of-function variants can cause developmental and vascular disorders.
0 ClinVar pathogenic / likely pathogenic and 0 uncertain variants in PDGFRB have source records linked to Interstitial lung disease. Association strength is not clinical gene validity.
ABCA3: Phospholipid-transporting ATPase ABCA3
It transports phospholipids into lamellar bodies of alveolar type II cells, supporting pulmonary surfactant assembly and normal gas exchange. Biallelic loss-of-function variants can cause neonatal respiratory failure or childhood interstitial lung disease.
0 ClinVar pathogenic / likely pathogenic and 11 uncertain variants in ABCA3 have source records linked to Interstitial lung disease. Association strength is not clinical gene validity.
Weakly linked (only a few uncertain records): NKX2-1.
ClinVar pathogenic and likely pathogenic variants linked to Interstitial lung disease
| Variant | Position | Protein part | Clinical label |
|---|---|---|---|
| SFTPC Y106H | 106 | BRICHOS | Pathogenic / likely pathogenic (★) |
Same protein, different disease
- Surfactant metabolism dysfunction, pulmonary also has ClinVar records linked to SFTPC variants; they fall mostly in different places as the Interstitial lung disease variants (7 pathogenic / likely pathogenic).
- Pulmonary alveolar proteinosis also has ClinVar records linked to SFTPC variants; they fall mostly in different places as the Interstitial lung disease variants (4 pathogenic / likely pathogenic).
Diseases related to Interstitial lung disease
- Idiopathic pulmonary fibrosis, also linked to FGFR1, FGFR4, PDGFRA, PDGFRB and 2 more
- Non-small cell lung carcinoma, also linked to FGFR1, FGFR4, PDGFRA and PDGFRB
- Acute myeloid leukemia, also linked to PDGFRA, PDGFRB and TERT
- Colorectal cancer, also linked to FGFR1, PDGFRA and PDGFRB
- Renal cell carcinoma, also linked to FGFR1, PDGFRA and PDGFRB
- Gastrointestinal stromal tumor, also linked to PDGFRA and PDGFRB
- Pulmonary alveolar proteinosis, also linked to ABCA3 and SFTPC
- Surfactant metabolism dysfunction, pulmonary, also linked to ABCA3 and SFTPC
- Hepatocellular carcinoma, also linked to PDGFRB and TERT
- Loeys-Dietz syndrome, also linked to ABCA3
- Hypogonadotropic hypogonadism 2 with or without anosmia, also linked to FGFR1
- Ovarian cancer, also linked to PDGFRA
Frequently asked questions
Which genes have records linked to Interstitial lung disease?
This view contains 7 analyzed proteins: SFTPC, TERT, FGFR1, FGFR4, PDGFRA and 2 more. Links come from clinical records and association databases. They do not imply that every listed gene is a validated cause, and missing genes may not yet be analyzed.
What do the clinical classifications mean?
Linked records include 1 pathogenic or likely pathogenic variants, 23 variants of uncertain significance and 13 with conflicting classifications. Labels summarize source records; multi-condition records may not make a separate assertion for this disease. Check the original record and review status.
Does the evidence score change a VUS classification?
No. 0 VUS or conflicting variants reach the likely-pathogenic points range on the computable criteria available here. This is a research prioritization signal, not a clinical classification. Patient, family and other required evidence may be missing.
Can I download the variant evidence?
Download the CSV for all 38 variants in the selected disease scope, including clinical labels, review status, evidence criteria, predictor scores, functional measurements and population frequency where available.
About this data
Variant–disease links come from ClinVar, Open Targets and UniProt, pooled from eligible public CATVariant analyses of each human protein. Evidence scores use the ACMG/AMP Bayesian points scale with computable criteria only (position among known disease variants, rarity in gnomAD, calibrated predictors, deep mutational scanning); there is no family or patient data, so they prioritise variants for expert review and never classify them.
Download every variant as CSV · Browse all diseases · Methods · About the Center